Interestingly, recent findings indicate that the presence of BRCA1 mutations is associated with augmented proliferation of luminal progenitor cells [29–32] and, thus, JQ1 could be used in pre-neoplastic tissue to block these hyperactive cells in their course towards full cancer development. This evidence concerns the gene BRCA1 and cancer.